Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Soumon Rudra"'
Autor:
Olga L. Green, PhD, Lauren E. Henke, MD, MSCI, Alex Price, MS, Areti Marko, BS RTT, Erin J. Wittland, BS, RTT, Soumon Rudra, MD, Hyun Kim, MD, Sasa Mutic, PhD, Jeff Michalski, MD, MBA, Clifford G. Robinson, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 4, Pp 100662- (2021)
Externí odkaz:
https://doaj.org/article/5b2974d86fdb475da1f11845f52db3eb
Autor:
Soumon Rudra, Naomi Jiang, Stephen A. Rosenberg, Jeffrey R. Olsen, Michael C. Roach, Leping Wan, Lorraine Portelance, Eric A. Mellon, Anna Bruynzeel, Frank Lagerwaard, Michael F. Bassetti, Parag J. Parikh, Percy P. Lee
Publikováno v:
Cancer Medicine, Vol 8, Iss 5, Pp 2123-2132 (2019)
Abstract Background Adaptive magnetic resonance imaging‐guided radiation therapy (MRgRT) can escalate dose to tumors while minimizing dose to normal tissue. We evaluated outcomes of inoperable pancreatic cancer patients treated using MRgRT with and
Externí odkaz:
https://doaj.org/article/f30e8ac561b748a5a3604eb81c6ea0df
Autor:
Comron Hassanzadeh, MD, MPH, Soumon Rudra, MD, Ani Bommireddy, BA, William G. Hawkins, MD, Andrea Wang-Gillam, MD, PhD, Ryan C. Fields, MD, Bin Cai, PhD, Justin Park, PhD, Olga Green, PhD, Michael Roach, MD, Lauren Henke, MD, Hyun Kim, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100506- (2021)
Purpose: Patients with inoperable pancreatic adenocarcinoma have limited options, with traditional chemoradiation providing modest clinical benefit and an otherwise poor prognosis. Stereotactic body radiation therapy for pancreatic cancer is limited
Externí odkaz:
https://doaj.org/article/d8503a078e544338b1bba5cb23c0ce94
Autor:
Soumon Rudra, MD, Amit Roy, MD, Randall Brenneman, MD, Prashant Gabani, MD, Michael C. Roach, MD, Laura Ochoa, ANP, PhD, Heidi Prather, DO, Catherine Appleton, MD, Julie Margenthaler, MD, FACS, Lindsay L. Peterson, MD, MSCR, Nusayba A. Bagegni, MD, Jacqueline E. Zoberi, PhD, Jose Garcia-Ramirez, MS, Maria A. Thomas, MD, PhD, Imran Zoberi, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100602- (2021)
Purpose: Our purpose was to describe the risk of radiation-induced brachial plexopathy (RIBP) in patients with breast cancer who received comprehensive adjuvant radiation therapy (RT). Methods and Materials: Records for 498 patients who received comp
Externí odkaz:
https://doaj.org/article/6fdef972425141e6a41a2118f4201984
Autor:
Ashley J. Schlafstein, Allison E. Withers, Soumon Rudra, Diana Danelia, Jeffrey M. Switchenko, Donna Mister, Saul Harari, Hui Zhang, Waaqo Daddacha, Shahrzad Ehdaivand, Xiaoxian Li, Mylin A. Torres, David S. Yu
Publikováno v:
International Journal of Breast Cancer, Vol 2018 (2018)
Failure to achieve pathologic complete response is associated with poor prognosis in breast cancer patients following neoadjuvant chemotherapy (NACT). However, prognostic biomarkers for clinical outcome are unclear in this patient population. Cyclin-
Externí odkaz:
https://doaj.org/article/33a4a2a95b42440e8020da2048abadae
Locoregional and Distant Recurrence Patterns in Young versus Elderly Women Treated for Breast Cancer
Autor:
Soumon Rudra, David S. Yu, Esther S. Yu, Jeffrey M. Switchenko, Donna Mister, Mylin A. Torres
Publikováno v:
International Journal of Breast Cancer, Vol 2015 (2015)
Objective. This study examined recurrence patterns in breast cancer patients younger than age of 40 and older than age of 75, two groups that are underrepresented in clinical trials and not routinely screened by mammography. Methods. The records of 2
Externí odkaz:
https://doaj.org/article/b97b4e427ba04ea284d1e047db2793ae
Autor:
Mark W. McDonald, James E. Bates, Neal S. McCall, Subir Goyal, Yuan Liu, Soumon Rudra, Jill S. Remick, Sibo Tian, Mark W. El-Deiry, Nabil F. Saba, William A. Stokes, Erica Swinney
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 116:404-412
Autor:
Ashley Schlafstein, Subir Goyal, Ashley Aiken, Jill Remick, Nabil Saba, James Bates, Soumon Rudra, Mark McDonald, Azeem Kaka, William Stokes
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:CLO23-057
Autor:
James R. Janopaul‐Naylor, Manali Rupji, Rachel A. Tobillo, Joshua W. Lorenz, Jeffrey M. Switchenko, Sibo Tian, Azeem S. Kaka, David C. Qian, Ashley J. Schlafstein, Conor E. Steuer, Jill S. Remick, Soumon Rudra, Mark W. McDonald, Nabil F. Saba, William A. Stokes, Mihir R. Patel, James E. Bates
Publikováno v:
Head & Neck. 45:658-663
Postoperative mortality for oropharynx squamous cell carcinoma (OPSCC) with transoral robotic surgery (TORS) varies from 0.2% to 6.5% on trials; the real-world rate is unknown.NCDB study from 2010 to 2017 for patients with cT1-2N0-2M0 OPSCC with Char
Autor:
Nabil F. Saba, Conor E. Steuer, Asari Ekpenyong, Ashley McCook-Veal, Kelly Magliocca, Mihir Patel, Nicole C. Schmitt, William Stokes, James E. Bates, Soumon Rudra, Jill Remick, Mark McDonald, Marin Abousaud, Aik Choon Tan, Muhammad Zaki Hidayatullah Fadlullah, Ritu Chaudhary, Jameel Muzaffar, Kedar Kirtane, Yuan Liu, Georgia Z. Chen, Dong M. Shin, Yong Teng, Christine H. Chung
Publikováno v:
Nat Med
Anti-programmed cell death protein 1 (PD-1) therapy is a standard of care in recurrent metastatic head and neck squamous cell carcinoma (RMHNSCC). Vascular endothelial growth factor inhibitors, including tyrosine kinase inhibitors, have immunomodulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c3f7a8d7cc7589573626837a085c392
https://europepmc.org/articles/PMC10205145/
https://europepmc.org/articles/PMC10205145/